0001209191-20-036360.txt : 20200612 0001209191-20-036360.hdr.sgml : 20200612 20200612173259 ACCESSION NUMBER: 0001209191-20-036360 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200413 FILED AS OF DATE: 20200612 DATE AS OF CHANGE: 20200612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Galante Joseph C CENTRAL INDEX KEY: 0001632384 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 20961222 MAIL ADDRESS: STREET 1: 111 TENTH AVENUE STREET 2: SUITE 200 CITY: NASHVILLE STATE: TN ZIP: 37203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-04-13 0 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001632384 Galante Joseph C 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203 1 0 0 0 Common Stock 2020-04-13 4 P 0 75 4.03 A 17767 D Common Stock 2020-04-15 4 P 0 150 4.05 A 17917 D Common Stock 2020-04-17 4 P 0 150 4.04 A 18067 D Common Stock 2020-04-21 4 P 0 150 4.03 A 18217 D Common Stock 2020-04-23 4 P 0 150 4.03 A 18367 D Common Stock 2020-04-27 4 P 0 150 4.02 A 18517 D Common Stock 2020-04-29 4 P 0 150 4.01 A 18667 D Common Stock 2020-05-01 4 P 0 150 4.01 A 18817 D Common Stock 2020-05-05 4 P 0 150 3.99 A 18967 D Common Stock 2020-05-07 4 P 0 150 3.97 A 19117 D Common Stock 2020-05-11 4 P 0 150 4.02 A 19267 D Common Stock 2020-05-13 4 P 0 150 3.93 A 19417 D Common Stock 2020-05-14 4 P 0 75 3.81 A 19492 D Common Stock 2020-05-15 4 P 0 75 3.76 A 19567 D Common Stock 2020-05-18 4 P 0 75 3.82 A 19642 D Common Stock 2020-05-19 4 P 0 75 3.78 A 19717 D Common Stock 2020-05-20 4 P 0 75 3.77 A 19792 D Common Stock 2020-05-21 4 P 0 75 3.68 A 19867 D Common Stock 2020-05-22 4 P 0 75 3.61 A 19942 D Common Stock 2020-05-26 4 P 0 75 3.59 A 20017 D Common Stock 2020-05-27 4 P 0 75 3.49 A 20092 D Common Stock 2020-05-28 4 P 0 75 3.34 A 20167 D Common Stock 2020-05-29 4 P 0 75 3.35 A 20242 D Common Stock 2020-06-01 4 P 0 75 3.45 A 20317 D Common Stock 2020-06-02 4 P 0 75 3.35 A 20392 D Common Stock 2020-06-03 4 P 0 75 3.29 A 20467 D Common Stock 2020-06-04 4 P 0 75 3.31 A 20542 D Common Stock 2020-06-05 4 P 0 75 3.44 A 20617 D Common Stock 2020-06-08 4 P 0 75 3.54 A 20692 D Common Stock 2020-06-09 4 P 0 75 3.48 A 20767 D The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Joseph C. Galante by /s/ Michael Bonner as attorney-in-fact 2020-06-12